Clinical Trial Update: A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting results for multiple oral doses of JNJ-41443532 in patients with type 2 diabetes mellitus; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• JNJ-41443532

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2013-12-11